Celon Pharma S.A. Announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was PLN 57.669 million compared to PLN 43.077 million a year ago. Operating income was PLN 1.528 million compared to PLN 4.097 million a year ago. Net income was PLN 2.017 million compared to PLN 3.460 million a year ago. Basic earnings per share was PLN 0.01 compared to PLN 0.08 a year ago. For the half year, total revenue was PLN 105.096 million compared to PLN 77.091 million a year ago. Operating income was PLN 1.910 million compared to PLN 1.765 million a year ago. Net income was PLN 302,000 compared to PLN 982,000 a year ago. Basic earnings per share was PLN 0.01 compared to PLN 0.02 a year ago.